Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_assertion type Assertion NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_head.
- NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_assertion description "[We conclude that low serum 1,25-D3 levels, at least in part, account for the decrease in VDR content in parathyroid glands of uremic rats and that treatment with 1,25-D3 or OCT prevents this decrease ameliorating the development of secondary hyperparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_provenance.
- NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_assertion evidence source_evidence_predicted NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_provenance.
- NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_assertion SIO_000772 8807569 NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_provenance.
- NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_assertion wasDerivedFrom rgd-2016 NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_provenance.
- NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_assertion wasGeneratedBy ECO_0000218 NP66819.RAGt5S5d0_FbXpXt8foRwVR60T9MhIZBbDGCuqvfvNWG8130_provenance.